Gevo Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Gevo de 41.9% y 42.1% por año respectivamente. Se prevé que el BPA crezca en un 45.3% al año. Se espera que la rentabilidad financiera sea de -20.7% en 3 años.

Información clave

32.1%

Tasa de crecimiento de los beneficios

45.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Oil and Gas	2.1%
Tasa de crecimiento de los ingresos	41.4%
Rentabilidad financiera futura	-20.7%
Cobertura de analistas	Low
Última actualización	23 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Earth First Investments 4: 2022 Is Key Year For Gevo's Biofuel Commercialization

Apr 05

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Mar 09

Is Gevo Stock Undervalued Or Overvalued? Focus On The Execution First

Dec 16

Is Gevo Stock A Buy, Sell, Or Hold During The Dip?

Dec 07

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Nov 05

Best Of Seeking Alpha Blog Posts Newsletter: Gevo Signs Deals For Renewables With Big Oil

Sep 15

Gevo Will Put You At A Crossroad

Jul 06

Gevo set to join Russell 3000 Index

Jun 08

Here's Why Gevo, Inc.'s (NASDAQ:GEVO) CEO May Deserve A Raise

Jun 04

If We Don't See A Short Squeeze, Gevo May Decline

Apr 27

Gevo Is +850% In 2 Months, Here's What's Next

Feb 02

Gevo pays off remaining $12.7M of Whitebox convertible senior secured notes

Jan 06

GEVO stock eases back after doubling in December

Dec 29

Health Check: How Prudently Does Gevo (NASDAQ:GEVO) Use Debt?

Dec 20

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:GEVO - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	115	-120	-954	-126	4
12/31/2025	30	-82	-710	-75	4
12/31/2024	20	-74	-219	-48	4
12/31/2023	17	-66	-108	-54	N/A
9/30/2023	13	-73	-101	-41	N/A
6/30/2023	9	-101	-124	-65	N/A
3/31/2023	5	-100	-116	-60	N/A
12/31/2022	1	-98	-128	-44	N/A
9/30/2022	1	-89	-155	-52	N/A
6/30/2022	0	-60	-144	-46	N/A
3/31/2022	1	-65	-146	-54	N/A
12/31/2021	1	-59	-114	-48	N/A
9/30/2021	1	-61	-78	-33	N/A
6/30/2021	1	-53	-46	-28	N/A
3/31/2021	2	-41	-29	-20	N/A
12/31/2020	6	-40	-25	-19	N/A
9/30/2020	12	-29	-23	-21	N/A
6/30/2020	18	-31	-25	-22	N/A
3/31/2020	22	-32	-27	-22	N/A
12/31/2019	24	-29	-27	-21	N/A
9/30/2019	24	-29	-28	-20	N/A
6/30/2019	27	-27	-24	-18	N/A
3/31/2019	31	-32	-22	-17	N/A
12/31/2018	33	-28	-18	-16	N/A
9/30/2018	33	-25	-15	-14	N/A
6/30/2018	32	-23	-16	-15	N/A
3/31/2018	30	-21	-18	-17	N/A
12/31/2017	28	-25	-23	-21	N/A
9/30/2017	27	-23	N/A	-21	N/A
6/30/2017	26	-28	N/A	-23	N/A
3/31/2017	27	-40	N/A	-23	N/A
12/31/2016	27	-37	N/A	-21	N/A
9/30/2016	29	-43	N/A	-23	N/A
6/30/2016	30	-40	N/A	-25	N/A
3/31/2016	31	-32	N/A	-24	N/A
12/31/2015	30	-36	N/A	-28	N/A
9/30/2015	32	-39	N/A	-27	N/A
6/30/2015	34	-34	N/A	-29	N/A
3/31/2015	33	-37	N/A	-35	N/A
12/31/2014	28	-41	N/A	-39	N/A
9/30/2014	20	-47	N/A	-48	N/A
6/30/2014	11	-62	N/A	-53	N/A
3/31/2014	6	-60	N/A	-51	N/A
12/31/2013	8	-67	N/A	-47	N/A
9/30/2013	8	-63	N/A	-52	N/A
6/30/2013	8	-59	N/A	-63	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que GEVO siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que GEVO siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que GEVO siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (42.1% al año) de GEVO crezcan más rápidamente que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (42.1% al año) de GEVO crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: GEVO se prevé que no sea rentable en 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Gevo Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

No longer forecast to breakeven

Price target increased by 10% to US$4.64

No longer forecast to breakeven

Price target decreased by 17% to US$4.95

Price target increased by 19% to US$7.43

Forecast to breakeven in 2025

Recent updates

Gevo, Inc. to Report Q1, 2024 Results on May 02, 2024

Gevo, Inc., Annual General Meeting, May 21, 2024

Full year 2023 earnings: EPS misses analyst expectations

No longer forecast to breakeven

Gevo Receives Notice from the Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement

Gevo, Inc. Hires Damien Perriman as Chief Business Development Officer

Gevo, Inc. to Report Q4, 2023 Results on Mar 07, 2024

Price target increased by 10% to US$4.64

Gevo, Inc. has filed a Follow-on Equity Offering in the amount of $500 million.

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Gevo, Inc. Appoints Angelo Amorelli as Board of Directors

Gevo, Inc. to Report Q3, 2023 Results on Nov 08, 2023

New minor risk - Share price stability

Gevo, Inc. Announces the Resignation of Timothy J. Cesarek, Chief Commercial Officer, Effective September 22, 2023

CEO & Director notifies of intention to sell stock

New minor risk - Profitability

No longer forecast to breakeven

Price target decreased by 17% to US$4.95

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 19% to US$7.43

CEO & Director notifies of intention to sell stock

Forecast to breakeven in 2025

Gevo, Inc. Appoints Nancy N. Young as Chief Sustainability Officer

Price target decreased by 8.8% to US$5.93

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Independent Director notifies of intention to sell stock

Price target increased by 15% to US$7.90

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 12%

Consensus EPS estimates fall by 25%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Consensus revenue estimates decrease by 12%

Gevo, Inc. to Report Q4, 2022 Results on Mar 09, 2023

Less than half of directors are independent

Gevo, Inc. Appoints Carol Battershell to Board of Directors

Forecast to breakeven in 2025

Consensus forecasts updated

Consensus revenue estimates increase by 22%

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Gevo, Inc. Reports Impairment Loss for the Third Quarter Ended September 30, 2022

Gevo, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Is Gevo (NASDAQ:GEVO) Weighed On By Its Debt Load?

Gevo Inc. Is Strongly On Track To Become A Leader In The SAF Market

Price target decreased to US$12.33

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Gevo Has Finally Reached Levels That Make The Shares Attractive

Gevo, Inc. announces renewable natural gas project in Northwest Iowa has been producing biogas

Consensus forecasts updated

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Price target decreased to US$10.00

Consensus forecasts updated

Consensus forecasts updated

Gevo, Inc., Annual General Meeting, Jun 01, 2022

No longer forecast to breakeven

Earth First Investments 4: 2022 Is Key Year For Gevo's Biofuel Commercialization

Independent Director recently sold US$453k worth of stock

Gevo, Inc. Appoints Alisher Nurmat as Principal Accounting Officer of the Company

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Gevo, Inc. Announces Retirement of Carolyn Romero as Chief Accounting Officer and Principal Accounting Officer, Effective March 4, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target decreased to US$12.25

Forecast to breakeven in 2024

Is Gevo Stock Undervalued Or Overvalued? Focus On The Execution First

Is Gevo Stock A Buy, Sell, Or Hold During The Dip?

Third quarter 2021 earnings released: US$0.072 loss per share (vs US$0.089 loss in 3Q 2020)